People: Synageva BioPharma Corp (GEVA.O)
7 Mar 2014
Mr. Stephen R. Davis is Independent Director of Synageva BioPharma Corp., since June 2007. From April 2010 until December 2012, Mr. Davis was the Chief Operating Officer of Ardea Biosciences, Inc. Prior to joining Ardea, Mr. Davis served as President and Chief Executive Officer of Neurogen Corporation, which was acquired by Ligand Pharmaceuticals in December 2009. Prior to becoming Chief Executive Officer in February 2008, Mr. Davis served as Neurogen’s Chief Operating Officer beginning in April 2005 and Executive Vice President and Chief Business Officer from September 2001 through April 2005. Mr. Davis was also a director of Neurogen until December 2009. Mr. Davis joined Neurogen in 1994 as Vice President of Finance and Chief Financial Officer. Since July 2012 and from 2010 to 2011 Mr. Davis served on the Board of Directors of A.P. Pharma. A.P. Pharma is, and Neurogen prior to its acquisition by Ligand was, a publicly-traded company. From 1990 through June 1994, Mr. Davis was a corporate and securities attorney at Milbank, Tweed, Hadley& McCloy LLP. Previously, Mr. Davis practiced as a Certified Public Accountant with Arthur Andersen & Co. Mr. Davis received his B.S. in Accounting from Southern Nazarene University and a J.D. from Vanderbilt University.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|